Targeting RPS6KC1 to overcome enzalutamide resistance in prostate cancer. - Ji FH; Qian YH; Guo XC; Liao HH; Huang JC; Xu ZH; Yu MM; Wu YY; Bao JW; Chen HJ; Yu YJ; Wang L (Biomarker research, 2025)